Skip to main content
Clinical Trials/IRCT20180404039187N8
IRCT20180404039187N8RecruitingPhase 3

Study of the effect of Curcumin in patients with Primary Dysmenorrhea

Tabriz University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 35 years (—)
Sex
Female

Inclusion Criteria

  • Patients with Primary Dysmenorrhea
  • Aged 18 to 35 years old
  • Having at least four recent consecutive painful menstrual cycles during the past six months
  • Bleeding of 3 to 7 days during the menstruation

Exclusion Criteria

  • Taking contraceptives within the past two months
  • Using intra-uterine device or drugs containing Curcumin within the past six months
  • Smoking an alcohol consumption

Investigators

Similar Trials